NSAID GI deaths
This article was originally published in The Tan Sheet
Severe gastrointestinal bleeding causes 15 deaths for every 100,000 users of NSAIDs or aspirin, a Spanish study published in the August American Journal of Gastroenterology finds. The study, which was based on death counts collected from 26 hospitals in 2001, discovered that up to one third of hospitalizations and deaths attributed to GI bleeding is related to NSAID/aspirin use, Angel Lanas, MD, University Hospital, Zaragoza, Spain, et al., state. Up to one third of all NSAID/aspirin deaths can be attributed to low-dose aspirin use, researchers observed. Out of 8,101 reported severe GI events, death occurred in 5.7% of cases...
You may also be interested in...
Use of per- and polyfluoroalkyl substances in cosmetic products appears to be declining, based on voluntary industry registrations with the US Food and Drug Administration. In any event, NGOs are gunning for PFAS' elimination, and the FDA says available data have yet to give a complete safety picture for PFAS used intentionally in cosmetics or present as impurities.
Exec Chat: How Edwards Lifesciences Deploys AI, Remote Monitoring To Help Doctors Make Life-Critical Decisions
Edwards Lifesciences’ head of critical care expects that “smart recovery” AI-driven products will grow the fastest in its critical care unit, which is expected to reach $800m in total revenues for 2021.
I.V. Korsuva now has an August FDA action date, which partner Vifor would commercialize in the ESRD dialysis setting while Cara works toward a broad anti-pruritus label for its oral tablet formulation.